Potency index, ratio of crizotinib IC50 to test compound IC50 for cytotoxicity against human NCI-H3122 cells harboring EML4-ALK E13;A20 mutant

Basic Information

ID: ALA4378249

Type: Functional

Description: Potency index, ratio of crizotinib IC50 to test compound IC50 for cytotoxicity against human NCI-H3122 cells harboring EML4-ALK E13;A20 mutant

Format: BAO_0000219

Organism: Homo sapiens

Cell type: NCI-H3122

Target: NCI-H3122(ALA4296475)

Document: ALA4376817

Potency index, ratio of crizotinib IC50 to test compound IC50 for cytotoxicity against human NCI-H3122 cells harboring EML4-ALK E13;A20 mutant: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4378249

Ratio IC50

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
561.45	4.72	4.72

Parent Molecular Weight

ALogP

Polar Surface Area

561.45

4.72

Potency index, ratio of crizotinib IC50 to test compound IC50 for cytotoxicity against human NCI-H3122 cells harboring EML4-ALK E13;A20 mutant

Basic Information

Activity Charts

Compound Summary